Object. Difficulty with step initiation, called "start hesitation," is related to gait bradykinesia and is an early hallmark of gait freezing in Parkinson disease (PD). Authors of this study investigated the effects of deep brain stimulation (DBS) and levodopa on step initiation before and 6 months after DBS surgery in 29 patients with PD who were randomized to either the bilateral subthalamic nucleus (STN) or globus pallidus internus (GPi) as the DBS site.
S
tep initiation is impaired in people with PD, resulting in the clinically observed impairments of start hesitation and gait freezing. 5, 9 Studies have shown that problems with step initiation in PD are often caused by a reduced size of postural preparation for single limb support. 19, 36 The feed-forward postural preparation that precedes the onset of voluntary movements, such as voluntary step initiation, is referred to as "anticipatory postural adjustments." 5, 6, 10, 26, 31 Preparation for a voluntary step involves displacement of the COP (that is, application point of resultant ground reaction force) backward and laterally toward the swing limb that results in movement of the body center of mass forward and over the stance limb. 5, 31 Anticipatory postural adjustments are thought to involve separate neural circuitry from voluntary movements, with coupling between the postural preparation and voluntary step occurring in the medullary reticular formation Effects of deep brain stimulation in the subthalamic nucleus or globus pallidus internus on step initiation in Parkinson disease that receives projections from the basal ganglia and is affected by PD. 40, 41 In addition, APAs probably involve the supplementary motor area, which is suppressed in patients with PD. 18, 22, 31 The small APA amplitudes in patients with PD have been shown to significantly increase with levodopa, 36 but the effects of DBS on step initiation is unclear. 11, 28 In the present study, we characterized both APAs prior to self-initiated steps and the steps themselves in 29 patients with PD before functional neurosurgery and 6 months after electrodes were implanted. As part of a Veterans Affairs/National Institute of Neurological Disorders and Stroke multicenter, double-blind clinical trial comparing target sites for DBS, patients were randomized to DBS surgery in either the STN or the GPi. 44 Deep brain stimulation provides remarkable benefits and generally betters the same symptoms improved by levodopa in PD. 2, 25, 38 Stimulation of the STN or GPi reduces bradykinesia, rigidity, tremor, and some gait difficulties. 34 However, we recently found that DBS surgery impairs automatic postural responses to external perturbations, which are also not improved with levodopa. 42 Impairment of automatic postural responses after DBS surgery is consistent with the observation that the number of falls may increase after DBS surgery, especially after electrodes are implanted in the STN. 16 Moreover, our recent meta-analysis showed that the postural instability and gait disorder subscore of the motor UPDRS continues to worsen 5 years after DBS surgery, especially in the STN, despite minimal long-term deterioration of the cardinal signs measured by the UPDRS. 43 In the present study, we investigated whether DBS has the same effect as levodopa in improving step initiation in PD. 5, 36 We evaluated step initiation in the levodopa on and off conditions both before surgery and 6 months after surgery when the short-term effects of surgery had stabilized. 8 The aims of this study were to determine the effects of DBS on step initiation on and off levodopa and to compare the effects of DBS in the STN and GPi on step initiation.
Methods

Patients and Controls
Twenty-nine patients with idiopathic PD who underwent DBS surgery participated in this study (PD-DBS group, mean age 61.3 ± 7.7 years); 22 of these patients constituted a smaller cohort from a large, multicenter clinical trial of DBS 44 and were recruited from the Seattle and Portland sites. All of the patients were randomized to 1 of 2 DBS surgical site groups: the GPi (14 patients) or the STN (15 patients).
There were 2 control groups: 28 healthy control volunteers (CTRL group, mean age 62.4 ± 7.4 years) and 9 controls with PD (disease duration 11.6 ± 6.3 years) who met the criteria for, but did not undergo, DBS surgery (PD-C group, mean age 60.3 ± 7.8 years).
All participants in the study gave informed consent in accordance with the Oregon Health & Science University and the Veterans Administration Medical Center Institutional Review Board regulations for human subject studies. Table 1 summarizes the clinical characteristics of patients in the PD-DBS group when entering the study.
Surgical Procedure
Patients in the PD-DBS group were randomly assigned (following a double-blind method) into either the STN (15 patients) or the GPi (14 patients) group. Both the patients and the experimenters remained unaware of the stimulation site for the duration of the multicenter study. The surgical procedure was performed by a neurosurgeon (K.J.B.) with extensive experience in DBS surgeries. Patients underwent surgical implantation of the DBS electrodes (model 3387, Medtronic, Inc.), which were inserted bilaterally through 2 precoronal sulcus bur holes. Intraoperative microelectrode recordings were performed to confirm target localization, and corrections to the implant site were made accordingly. One week after electrode implantation, a single-(Soletra, Medtronic, Inc.) or dualchannel (Kinetra, Medtronic, Inc.) internal pulse generator was surgically implanted in the infraclavicular area. Magnetic resonance imaging studies were available for 19 of the patients. For the STN, the target contact was the second contact (Contact 1), and for the GPI, the target contact was the most distal one (Contact 0). The mean (± standard deviation) distance of the target contacts relative to the anterior commissure-posterior commissure midpoint was as follows: x = 11.24 ± 1.45 mm, y = −4.01 ± 1.09 mm, and z = −4.86 ± 1.25 mm for the STN; and x = 20.33 ± 1.36 mm, y = −3.4 ± 1.6 mm, and z = −4.04 ± 1.15 mm for the GPi.
After the DBS stimulator was turned on, a movement disorders neurologist (P.H.) periodically adjusted the internal pulse generator parameters to empirically achieve optimized PD symptom control and the absence of marked side effects; she also made appropriate changes in the PD pharmacological therapy. The mean amplitude of DBS was 3.35 V (range 2.2-4.4 V), with 70% of the patients having a 90-mm pulse width (5 patients at 60 mm, 1 at 120 mm, and 2 at 150 mm) and 77% of the patients having a rate of 185 Hz (the rest of the patients were divided between 130 and 150 Hz).
Experimental Conditions and Procedures
Before surgery, patients in the PD-DBS group were tested in 2 conditions in the following order: 1) off condition: the practical off antiparkinson medication state with a medication washout of at least 12 hours; and 2) DOPA condition: on levodopa medication, with testing at least an hour after taking the usual dose. Patients were tested again 6 months after surgery in 4 different conditions in the following order: 1) DBS condition: testing with DBS stimulators turned on after a 12-hour levodopa washout; 2) off condition: testing with DBS stimulators turned off at least 30 minutes before testing and off medication; 3) DOPA condition: testing 1 hour after taking the usual dose of levodopa with stimulators off; and 4) DBS+DOPA condition: testing at least 30 minutes after DBS stimulators were switched on again while still on medication.
At the start of each trial, patients stood with each foot on separate side-by-side force plates. They were instruct-ed to voluntarily take 2 steps forward, starting with the right foot. Steps were self-initiated at the patient's normal, comfortable pace. Three trials of step initiation were performed, starting with the feet parallel, approximately 25 cm apart. Initial stance was made consistent across trials by having patients stand within tracings of their foot outlines on the force plates and by coaching them to maintain their habitual anteroposterior and mediolateral COP position as monitored by the experimenters on an oscilloscope.
To check for any practice or fatigue effects due to repeated trials, the CTRL group completed 1 test session with 4 sets of trials to match the 4 postsurgery conditions of the patients in the PD-DBS group. The PD-C group was tested (on and off medication) at baseline and 6 months later to determine if changes in step initiation were related to disease progression.
Clinical evaluation using the motor section (III) of the UPDRS 14 and the Hoehn and Yahr scale 21 was performed immediately before each test condition.
Data Acquisition and Analysis
The APA phase of step initiation was measured by the lateral COP excursion toward the initial swing limb. Magnitude of the APA was measured from the baseline to the peak lateral COP (peak COP). The APA duration was measured as the time from the onset of the first measurable change in lateral COP (APA start) to the time of foot-off (that is, the instant the vertical forces detected that the initial swing limb left the force plate). Four vertical force sensors under each force plate were used to calculate the position of the total body COP. Data from the force platform were acquired at 480 Hz and were lowpass filtered at 50 Hz.
The step initiation phase was characterized by the length and velocity of the first step measured via reflective markers placed on the right lateral malleolus that were detected by infrared cameras (Motion Analysis, Inc.). Velocity was computed as the ratio between step length and step duration. Kinematic data were acquired at 60 Hz.
The median of 3 step initiation trials was used to represent performance in each condition. For details on data acquisition and APA parameters, see Rocchi et al. 36 
Statistical Analyses
To calculate the statistical significance of comparisons made from our data set, a repeated-measures ANO-VA was used after checking for normal distribution of the data. Tests were performed on all of the APAs and steps.
For comparisons between the PD-DBS and CTRL groups, we applied a repeated-measures ANOVA using the group as the between factor.
A preliminary evaluation was performed to detect possible differences between patients with DBS in the STN or the GPi. To this aim, DBS site was the between factor and treatment condition was the within factor.
To detect differences due to the surgical procedure (pre-and postsurgery conditions) and the 4 different treatment conditions, an ANOVA was performed separately on the STN and GPi groups, considering only within factor(s) to evaluate: 1) presurgery responsiveness to levodopa (treatment as the within factor considering only presurgery data); 2) postsurgery responsiveness to levodopa, to DBS, and to their interaction (treatment as the within factor considering only postsurgery data); and 3) pre-and postsurgery comparisons, including the off states and the best-treatment states, namely, DOPA presurgery and DBS+DOPA postsurgery (surgery and treatment as within factors). In points 2 and 3, a post hoc multiple comparison test (all pairwise by the Fisher least significant difference test) was performed to detect pairs of means with statistically significant differences.
The repeated-measures ANOVA was also used to assess changes between baseline and 6 months postsurgery in the PD-C group and over repeated sessions within a day in the CTRL group. All statistical analyses were made using NCSS software.
Results
Anticipatory Postural Adjustment Phase
In the CTRL group (28 healthy control volunteers), APA magnitude and duration were not significantly different across the 4 sequential sessions. For this reason, the CRTL group mean (± standard error of the mean) for the first of the 4 experimental sessions was used in all figures.
In both presurgery conditions and all 4 postsurgery conditions, APA magnitude was smaller and APA dura- tion was longer in the PD-DBS group than in the CTRL group (p < 0.01). Representative APAs (lateral COP excursion) during step initiation are illustrated in Fig. 1A for a healthy control volunteer and a PD-DBS patient. The STN and GPi groups did not differ in response of APA variables across conditions, although differences were found between treatment conditions, as detailed below and shown in Fig. 1B and C. Anticipatory Postural Adjustment Magnitude. Before surgery, the peak COP was significantly increased by levodopa (p < 0.01) in both the STN and GPi groups, although it was significantly smaller in PD-DBS patients than in the CTRL group. These results were consistent with our findings in a previous study. 36 After surgery, the DOPA, DBS, and DBS+DOPA conditions had larger peak COP values than those for the postsurgery off condition for both the STN and GPi groups, but only the DBS+DOPA condition reached significance (p < 0.05 for both groups; Fig. 1B) . Peak COP in the postsurgery off condition was less than that in the presurgery off condition. Comparison of the best-treatment states before (DOPA) and after (DBS+DOPA) surgery showed that peak COP in the postsurgery condition was significantly less than that in the presurgery condition for both STN and GPi groups. In fact, after surgery, peak COP was no longer increased by levodopa in either the STN or GPi group.
Anticipatory Postural Adjustment Duration. Before surgery, levodopa decreased the APA duration closer to normal values but only in the STN group (p < 0.5). While this is consistent with levodopa effects in previous studies, 36 the GPi group did not have a significant levodopa effect, perhaps because APA duration in the presurgery off condition was already close to the CTRL group level. The best-treatment condition postsurgery (DBS+DOPA) improved (shortened) APA duration compared with the postsurgery off condition (p < 0.05 in both STN and GPi groups). The APA duration in the postsurgery off condition was longer than that in the presurgery off condition but did not reach statistical significance. Anticipatory postural adjustment duration was better (shorter) in the presurgery DOPA condition than in the DBS+DOPA condition (best-treatment states, p < 0.05 for both the STN and GPi groups; Fig. 1C ).
To better illustrate changes related to the surgery effect (presurgery off condition vs postsurgery off condition) and the best-treatment effect (presurgery DOPA vs postsurgery DBS+DOPA), we plotted the individual patient values along with group means (Fig. 2) . Note that the peak APA magnitude reduction after surgery in the off condition for both the STN and GPi groups was statistically significant (p < 0.05 in GPi and p < 0.005 in STN, post hoc multiple comparison test), and this reduction was consistent for all but 3 patients in the GPi group and all but 2 patients in the STN group. Similarly, a comparison between best-treatment conditions showed that DBS+DOPA was not as effective as levodopa presurgery in improving APA size (p < 0.005 in GPi and p < 0.05 in STN, post hoc multiple comparison test). Worsening of the APA amplitude after surgery was true for all but 2 patients in the GPi group and all but 3 patients in the STN group.
The peak COP and APA durations in the PD-C group were similar to those in the PD-DBS group before surgery, both when evaluated at baseline and at the 6-month follow-up (Fig. 3) . In both of these groups, the peak COP magnitude increased and APA duration decreased in the DOPA condition compared with those in the off condition (p < 0.05). No differences in these 2 measures were found between baseline and 6-month follow-up testing.
Stepping Phase
The repeated-measures ANOVA did not detect differences between the STN and GPi groups in terms of the surgery effect or response to treatments for both kinematic variables, that is, step length and velocity (Fig. 4) . Parkinson disease reduced the length (p < 0.01) and velocity (p < 0.01) of the first step compared with healthy controls. Before surgery, levodopa improved the stepping phase, since both length and velocity of the first step increased as compared with those in the off condition (length: p < 0.05 for STN and GPi groups; velocity: p < 0.05 for GPi group and p < 0.005 for STN group). For both the STN and GPi groups, length and velocity in the DBS+DOPA condition increased compared with those in the postsurgery off condition (p < 0.05). For the GPi group, length and velocity in the DBS+DOPA condition were restored to levels similar to those in the presurgery DOPA condition. For the STN group, although step length in the DBS+DOPA condition was restored to the presurgery DOPA level, velocity remained lower than in the presurgery DOPA condition (p < 0.05).
Clinical Evaluation
Before surgery, clinical signs, as measured using the motor section of the UPDRS, were greatly ameliorated in the DOPA condition compared with the off condition (p < 0.001). After surgery, results confirmed a reduction in clinical signs on any of the therapies compared with the off condition (p < 0.001) for both the STN and GPi groups. In fact, the administration of levodopa at the patient's usual dose along with activation of the stimulator resulted in a UPDRS motor score comparable to that in the presurgery DOPA condition. Values and more detailed data on the UPDRS motor scores in the 6 tested conditions are presented in Table 2 .
The PD-C patients had a UPDRS motor score comparable to that in the PD-DBS group, with 45.5 ± 16 and 22.9 ± 8.9 at baseline and 45.9 ± 12.8 and 24.2 ± 9.6 after 6 months (off and on levodopa, respectively). The levodopa-equivalent dose in the PD-C group was 1234 ± 450 mg/day at baseline and 1144 ± 326 mg/day after 6 months, values comparable to those in PD-DBS patients before surgery (Table 1) .
Discussion
Our results showed that 6 months of DBS can impair step initiation. Prior to surgery, the PD-DBS patients showed smaller than normal lateral weight shifts associated with APAs in preparation for a step as well as smaller and slower steps, which is consistent with findings in the literature. 7, 36 Also consistent with the literature, APA amplitude, step size, and velocity were improved with levodopa before surgery. 5, 36, 37 However, 6 months after DBS surgery, the size of the APA was smaller, the duration of step initiation was longer, and the presurgery improvement with levodopa was not restored.
The APAs were similarly impaired by DBS surgery in both the GPi and STN groups. In contrast, automatic postural responses to external perturbations in the same patients were impaired by DBS surgery in the STN group but not in the GPi group. 40 Similarly, jaw movements were impaired by DBS surgery only in the STN group but not in the GPi group. 35 Thus, DBS in the STN impaired APAs, automatic postural responses, and jaw movements, whereas DBS in the GPi impaired APAs but did not change automatic postural responses or jaw movements. These results suggest that the STN plays a similar role for these axial motor behaviors, whereas GPi circuitry may play different roles.
Two previous studies have focused on the effects of DBS in the STN on step initiation. 28, 38 Authors of both of these studies concluded that DBS in the STN improved step initiation. However, it is important to note that only postsurgery data were considered in these studies. We found similar small improvements in APAs in the DBS+DOPA condition, as compared with those in the postsurgery off condition (Fig. 1) . Nevertheless, APA amplitudes and durations were worse in the DBS+DOPA condition than in the presurgical DOPA condition. To our knowledge, our study is the first to compare movement initiation both pre-and post-DBS surgery.
Surprisingly, we found that levodopa and DBS produced different effects on step initiation. In fact, whereas levodopa improved APAs for step initiation, DBS in either the STN or the GPi impaired them. Previous studies showing that the effects of DBS on motor tasks are similar to those of levodopa are consistent with a simple circuitry model of PD. 1, 12 This model suggests that DBS and dopamine both inhibit excessive tonic basal ganglia outflow to thalamocortical and brainstem circuits. In contrast, in our study the positive effects of levodopa and the negative effects of DBS on APAs for step initiation suggest that DBS may have some nondopaminergic effects. In fact, the poor responsiveness of APAs to levodopa after surgery, as compared with before surgery, suggests that the DBS surgery itself impairs the action of levodopa on APAs.
A poor APA response to levodopa after surgery is probably not caused by a reduction in levodopa. In our patients, the levodopa-equivalent dose was slightly decreased after surgery as compared with before, with a significant change (p = 0.02) only in the STN group, which is consistent with findings in the literature. 7 However, a correlation between the decline in the APA peak and a change in the levodopa dose before and after sur- gery was not significant (p = 0.2 in GPi group, p = 0.75 in STN group). Although we cannot know the reason for the reduced levodopa effect after surgery, it is possible that the stabilization of abnormal basal ganglia network oscillations with DBS may in some way limit the effects of levodopa on specific postural tasks, such as step initiation, that depend on the interaction of the pedunculopontine nucleus and other locomotor brainstem areas and the supplementary motor area. 32 Although the physiological mechanisms responsible for DBS effects are unknown, long-term plastic changes of synapses and circuitry have been observed as a result of chronic DBS. 4, 27 We do not know whether the impairment in step preparation after DBS surgery was related to a lesion effect or to 6 months of continuous high-frequency stimulation in the basal ganglia, resulting in long-lasting alterations of circuits that are important for postural preparation, even when the stimulators were turned off. Future studies should compare step initiation before and after surgery but before the stimulators have been turned on to differentiate between a surgical procedure effect versus a chronic stimulation effect.
Our comparison with a PD control group that did not have DBS surgery dispels the likelihood that the worsening step initiation after DBS surgery is attributable to disease progression across 6 months. In fact, the PD controls had better step initiation with levodopa at both baseline and 6 months later, unlike the patients who underwent DBS surgery, who only improved with levodopa before surgery. Interestingly, movement execution was not as disrupted by DBS as postural preparation prior to movement. Specifically, step length was the same in the besttreatment states before and after surgery in both the GPi and STN groups, and step velocity was the same before and after surgery in the GPi group. The different effects of DBS on postural preparation and stepping suggest independent motor pathways for the preparation and execution of movement. 13 Studies recording neural activity in the reticular formation of the feline brainstem showed different neurons active during APAs and the movement phase. 13 In addition, recent studies demonstrated that APAs may be triggered independently of the step by an acoustic startle. 30, 39 Moreover, lesions isolated to the supplementary motor area resulted in a loss of APAs prior to arm movements, which were not affected by the lesion. 18, 31 From a clinical viewpoint, the motor score of the UPDRS was the same before and after surgery in the best-treatment conditions (DOPA presurgery and DBS+DOPA postsurgery), which is consistent with findings in the literature. 16 The UPDRS does not appear to be a sensitive measure of APAs prior to step initiation, so additional clinical tests of balance should be considered. 17 The lack of quantitative improvement in postural preparation for a step after DBS surgery is consistent with clinical studies suggesting that DBS may not be as effective a treatment for axial signs in patients with PD as it is for tremor, rigidity, and bradykinesia. 3, 5, 24 In fact, the Veterans Affairs/National Institute of Neurological Disorders and Stroke multicenter clinical trial comparing the STN and GPi as DBS sites also showed an increase in injurious falls after DBS surgery, especially for the STN group, although both groups otherwise benefited from surgery with fewer on/off fluctuations.
12,44
One limitation of our study was the difference in baseline APA duration and magnitude between the STN and GPi groups. This bias did not correlate with diversity in clinical signs and appeared even though PD-DBS patients were randomized to STN and GPi surgery sites. Although the sample in our study is quite large, when compared with populations in previous analogous works, 15, 20, 23, 28, 29, 38 our limited number of participants represents a limitation. Regardless, our study does have the advantage of considering both pre-and postsurgery conditions as well as both STN and GPi sites. In contrast, previous DBS studies examining step initiation and gait have only included postsurgery conditions for one DBS site. It is also noteworthy that we evaluated performance in several different axial tasks, such as speech 34 and postural responses, 40 as well as APAs prior to step initiation. A comprehensive evaluation of PD-DBS patients using a variety of motor tasks will allow a better understanding of the effects of DBS and the role of the basal ganglia in axial motor control.
Conclusions
Our study highlights the importance of comparing motor behavior pre-and postsurgery to determine the effects of DBS on patients with PD. Despite the many benefits of DBS for patients with PD, our study indicates potential postural issues associated with the initiation of walking, which may worsen start hesitation or freezing after surgery.
